Quarterly report pursuant to Section 13 or 15(d)

Statements of Stockholders' Equity (Unaudited)

v3.23.1
Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Class A Preferred Stock
Preferred Stock
Class A Common Shares
Common Shares
Common Shares
Common Shares
Common Stock Issuable
Additional Paid-in Capital
Accumulated Deficit
Total
Balances at Dec. 31, 2021     $ 9 $ 4,329 $ 359,906 $ (251,844) $ 112,400
Balances (in shares) at Dec. 31, 2021 250,000 845,385 6,238,866        
Issuance of common shares - Founders Agreement       (4,212) 4,212    
Issuance of common shares - Founders Agreement (in shares)     169,107        
Issuance of common shares, net of offering costs - At-the-Market Offering     $ 1   2,738   2,739
Issuance of common shares, net of offering costs - At-the-Market Offering (in shares)     184,920        
Issuance of common shares - Equity fee on At-the-Market Offering       (90) 163   73
Issuance of common shares - Equity fee on At-the-Market Offering (in shares)     6,292        
Issuance of common shares under ESPP         116   116
Issuance of common shares under ESPP (in shares)     10,485        
Stock-based compensation expenses         664   664
Stock-based compensation expenses (in shares)     12,524        
Issuance of common shares - Equity fee on RWG Debt         750   750
Issuance of common shares - Equity fee on RWG Debt (in shares)     63,662        
Issuance of warrants for RWG Debt         384   384
Net loss           (19,795) (19,795)
Balances at Mar. 31, 2022     $ 10 27 368,933 (271,639) 97,331
Balances (in shares) at Mar. 31, 2022 250,000 845,385 6,685,856        
Balances at Dec. 31, 2022     $ 11 1,109 374,522 (329,369) 46,273
Balances (in shares) at Dec. 31, 2022 250,000 845,385 7,100,111        
Issuance of common shares - Founders Agreement       (1,109) 1,109    
Issuance of common shares - Founders Agreement (in shares)     187,134        
Stock-based compensation expenses         235   235
Stock-based compensation expenses (in shares)     5,905        
Exercise of warrants (in shares)     92        
Reverse Split (15:1)     $ (10)   10    
Net loss           (16,693) (16,693)
Balances at Mar. 31, 2023     $ 1 $ 0 $ 375,876 $ (346,062) $ 29,815
Balances (in shares) at Mar. 31, 2023 250,000 845,385 7,293,242